Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Tyra Biosciences, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +1 vs. Q2 2022
- Shares held
- 35.7M
- −51.1K (−0.1%) vs. Q2 2022
- Total value
- $313.8M
- +$58.2M (+22.8%) vs. Q2 2022
- New holders
- 4
- 16 more added
- Sold out
- 3
- 16 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TYRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 168 | $2.22B |
| Q1 2026 | 164 | $2.52B |
| Q4 2025 | 133 | $1.49B |
| Q3 2025 | 116 | $778.4M |
| Q2 2025 | 121 | $541.5M |
| Q1 2025 | 117 | $499.5M |
| Q4 2024 | 113 | $675.8M |
| Q3 2024 | 95 | $1.11B |
| Q2 2024 | 79 | $748.6M |
| Q1 2024 | 77 | $768.4M |
| Q4 2023 | 62 | $495.2M |
| Q3 2023 | 59 | $502.1M |
| Q2 2023 | 59 | $616.7M |
| Q1 2023 | 51 | $573.0M |
| Q4 2022 | 46 | $267.8M |
| Q3 2022 | 49 | $313.8M |
| Q2 2022 | 48 | $255.6M |
| Q1 2022 | 46 | $386.6M |
| Q4 2021 | 45 | $494.2M |
| Q3 2021 | 26 | $456.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Tyra Biosciences, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 39 | $0 | 0.00% | −114−74.5% | Reduced |
| Ellevest, Inc. | 27 | $0 | 0.00% | +27 | New |
| Royal Bank of Canada | 160 | $1.00K | 0.00% | +86+116.2% | Added |
| The PNC Financial Services Group, Inc. | 58 | $1.00K | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 73 | $1.00K | 0.00% | +39+114.7% | Added |
| UBS Group AG | 91 | $1.00K | 0.00% | +91 | New |
| Citigroup Inc | 200 | $2.00K | 0.00% | −734−78.6% | Reduced |
| Barclays PLC | 556 | $5.00K | 0.00% | −102−15.5% | Reduced |
| Ameritas Investment Partners, Inc. | 940 | $8.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,405 | $12.0K | 0.00% | +444+46.2% | Added |
| Amalgamated Bank | 1,621 | $14.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,203 | $37.0K | 0.00% | +1,266+43.1% | Added |
| Deutsche Bank AG | 4,922 | $43.0K | 0.00% | −875−15.1% | Reduced |
| California State Teachers Retirement System | 5,180 | $46.0K | 0.00% | −432−7.7% | Reduced |
| American International Group, Inc. | 6,231 | $55.0K | 0.00% | +89+1.4% | Added |
| Fishman Jay A Ltd | 10,500 | $92.3K | 0.01% | +10,500 | New |
| New York State Common Retirement Fund | 10,525 | $93.0K | 0.00% | +37+0.4% | Added |
| Sepio Capital, LP | 10,625 | $93.0K | 0.01% | +10,625 | New |
| Morgan Stanley | 12,522 | $110.0K | 0.00% | −914−6.8% | Reduced |
| Bank of America Corp | 13,791 | $121.0K | 0.00% | −5,928−30.1% | Reduced |
| Nuveen Asset Management, LLC | 18,756 | $165.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 20,000 | $176.0K | 0.00% | −500−2.4% | Reduced |
| Rhumbline Advisers | 20,633 | $181.0K | 0.00% | +3,348+19.4% | Added |
| D. E. Shaw & Co., Inc. | 34,886 | $307.0K | 0.00% | −21,168−37.8% | Reduced |
| Bank of New York Mellon Corp | 39,250 | $345.0K | 0.00% | +7,339+23.0% | Added |
| Citadel Advisors LLC | 40,619 | $357.0K | 0.00% | −34,226−45.7% | Reduced |
| Wellington Management Group LLP | 85,182 | $748.0K | 0.00% | +30,318+55.3% | Added |
| Charles Schwab Investment Management Inc | 96,175 | $846.0K | 0.00% | +14,874+18.3% | Added |
| Northern Trust Corp | 103,808 | $912.0K | 0.00% | +674+0.7% | Added |
| Logos Global Management LP | 127,316 | $1.12M | 0.14% | −39,210−23.5% | Reduced |
| Sio Capital Management, LLC | 152,159 | $1.34M | 0.57% | 00.0% | Unchanged |
| State Street Corp | 217,988 | $1.92M | 0.00% | +3,963+1.9% | Added |
| JPMorgan Chase & Co | 219,547 | $1.93M | 0.00% | −4,945−2.2% | Reduced |
| Woodline Partners LP | 241,099 | $2.12M | 0.03% | −48,073−16.6% | Reduced |
| Geode Capital Management, LLC | 247,450 | $2.17M | 0.00% | +22,039+9.8% | Added |
| Perceptive Advisors LLC | 494,403 | $4.35M | 0.13% | 00.0% | Unchanged |
| Vanguard Group Inc | 599,953 | $5.27M | 0.00% | +8,844+1.5% | Added |
| BlackRock Inc. | 622,098 | $5.47M | 0.00% | −8,757−1.4% | Reduced |
| Janus Henderson Group PLC | 682,018 | $6.01M | 0.00% | −30,281−4.3% | Reduced |
| Cormorant Asset Management, LP | 743,988 | $6.54M | 0.46% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 945,707 | $8.31M | 2.49% | +49,289+5.5% | Added |
| Frazier Life Sciences Management, L.P. | 1,327,665 | $11.7M | 0.90% | −47,400−3.4% | Reduced |
| Fairmount Funds Management LLC | 1,416,998 | $12.5M | 2.30% | 00.0% | Unchanged |
| BVF Inc | 2,472,327 | $21.7M | 0.90% | 00.0% | Unchanged |
| Nextech Invest AG | 2,518,582 | $22.1M | 7.15% | 00.0% | Unchanged |
| FMR LLC | 4,026,301 | $35.4M | 0.00% | +58,211+1.5% | Added |
| Canaan Partners XI LLC | 4,409,991 | $38.8M | 15.63% | 00.0% | Unchanged |
| Boxer Capital, LLC | 6,448,359 | $56.7M | 3.19% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 7,236,454 | $63.6M | 1.36% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,663−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −12,910−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |